![Justin Ward](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Justin Ward
Directeur/Membre du Conseil chez RECCE PHARMACEUTICALS LTD
Fortune : 117 277 $ au 31/05/2024
Profil
Justin Ward is currently the Executive Director & Manager-Quality Assurance at Recce Pharmaceuticals Ltd.
He previously worked as a Laboratory Manager at Solbec Pharmaceuticals Ltd.
and as a Quality Manager at Phebra Pty Ltd.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
07/12/2023 | 301 444 ( 0,15% ) | 117 277 $ | 31/05/2024 |
Postes actifs de Justin Ward
Sociétés | Poste | Début |
---|---|---|
RECCE PHARMACEUTICALS LTD | Directeur/Membre du Conseil | 09/07/2019 |
Anciens postes connus de Justin Ward
Sociétés | Poste | Fin |
---|---|---|
Phebra Pty Ltd.
![]() Phebra Pty Ltd. Pharmaceuticals: MajorHealth Technology Phebra Pty Ltd. is an Australian-based specialty pharmaceutical group that develops, manufactures, and markets critical medicines worldwide. The private company is based in Lane Cove, AU, and has subsidiaries in the United Kingdom. The Australian company creates critical medicines that save and improve lives. Phebra was founded in 1993, and the CEO is Andre Vlok. | Corporate Officer/Principal | - |
Solbec Pharmaceuticals Ltd. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
RECCE PHARMACEUTICALS LTD | Health Technology |
Entreprise privées | 2 |
---|---|
Solbec Pharmaceuticals Ltd. | Health Technology |
Phebra Pty Ltd.
![]() Phebra Pty Ltd. Pharmaceuticals: MajorHealth Technology Phebra Pty Ltd. is an Australian-based specialty pharmaceutical group that develops, manufactures, and markets critical medicines worldwide. The private company is based in Lane Cove, AU, and has subsidiaries in the United Kingdom. The Australian company creates critical medicines that save and improve lives. Phebra was founded in 1993, and the CEO is Andre Vlok. | Health Technology |